Therapy News and Research

RSS

Two healthy diets stood out in a study of more than 7,000 adults

In a cross-sectional analysis of 7,256 adults from the Maastricht Study, researchers found that greater adherence to the DASH and Dutch Healthy Diet patterns was associated with higher very-low-frequency (VLF) heart rate variability power, particularly among participants not taking beta-blockers. No significant associations were observed across time-domain HRV measures after full adjustment, and the findings do not establish that these diets improve cardiovascular function.

2 Nov 2026

Targeting EGFR signaling to reduce mucus overproduction in lung diseases

Airway mucus is part of innate lung defense, but when production overwhelms clearance, it obstructs airflow and worsens disease.

2 Nov 2026

Qureight publishes in the European Respiratory Journal, calling for fibrosis burden to become the principal structural imaging biomarker for antifibrotic trials

Qureight, an end-to-end imaging company providing enterprise-grade imaging and precision endpoints for clinical trials for lung and heart disease, today announced the publication of a peer-reviewed Viewpoint in the European Respiratory Journal (ERJ).

From Qureight 2 Nov 2026

Randomized trial demonstrates enhanced stent expansion in severely calcified coronary nodules

A randomized clinical trial at The Mount Sinai Hospital found that combining two techniques for removing calcium nodules-rotational atherectomy and intravascular lithotripsy (IVL)-before coronary stent placement allowed stents to expand more fully than IVL alone in patients with calcified coronary nodules.

2 Nov 2026

Menopause reshapes women's careers, from brain fog to changing priorities

In a qualitative analysis of 130 Reddit posts, researchers examined how perimenopause and menopause affected women's career sustainability, finding that brain fog, fatigue, mood changes, and anxiety were associated with reduced confidence, workplace performance concerns, and threats to professional identity. The accounts revealed interconnected challenges involving health, happiness, and productivity, alongside experiences of supportive managers, online peer support, reduced working hours, and career reassessment that helped some women adapt to the transition.

1 Nov 2026

Could GLP-1 drugs help women with PCOS beyond weight loss?

A scoping review of 28 studies suggests that GLP-1 receptor agonists may improve androgen levels and menstrual function in women with polycystic ovary syndrome (PCOS), alongside their established metabolic benefits. Evidence for improved ovulation, fertility, and pregnancy outcomes remains limited, and the researchers could not determine whether reproductive benefits result directly from the drugs or from weight loss and improved metabolic health.

1 Nov 2026

$4 million NIH grant advances AI-guided heart failure treatment

A $4 million grant from the National Institutes of Health is helping faculty researchers in the University of Virginia School of Engineering and Applied Science develop an artificial intelligence tool to personalize treatments for people with heart failure.

30 Oct 2026

New database offers insights into psychedelic use outside clinical trials

Fireside Project today announced the publication of "The Fireside Database: Large-Scale Evidence from 25,419 Psychedelic Support Interactions" in Science Advances, providing researchers and policymakers with an unprecedented empirical window into psychedelic use and support outside clinical settings.

30 Oct 2026

Hemoadsorption may improve outcomes in severe poisoning cases

The WHO estimated over 800,000 suicide deaths in 2012, with poisoning a major concern. Three‑quarters of suicides occur in low‑ and middle‑income countries, with an estimated 30% related to pesticides.

30 Oct 2026

Norrin treatment prevents vision loss in diabetic rats

Over 100 million people in the U.S. are affected by diabetic retinopathy, a complication of diabetes that affects the eyes.

30 Oct 2026

FDA approves ILUMYA for adults with active psoriatic arthritis

Sun Pharmaceutical Industries Limited announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for ILUMYA® (tildrakizumab-asmn) for the treatment of adults with active psoriatic arthritis (PsA).

30 Oct 2026

Space-grown organoids better replicate aggressive glioblastoma tumors

Glioblastoma (GBM) is the most common malignant primary brain tumor in adults and is one of the most aggressive and deadly forms of cancer.

30 Oct 2026

Immunotherapy reshapes immune cell interactions in melanoma-affected lymph nodes

A new study from Mayo Clinic suggests checkpoint immunotherapy may reshape the immune environment within lymph nodes after melanoma has spread to them.

30 Oct 2026

Hyperactive cancer-promoting proteins help tumor cells evade immune attack

The immune system may recognize a cancer cell and still fail to destroy it. Researchers at Hiroshima University and their international collaborators found that hyperactive YAP and TAZ (YAP/TAZ), two cancer-promoting proteins, were associated with genomic instability that may make cancer cells more recognizable to the immune system, while also increasing PD-L2, which helps the cells suppress T-cell attack.

30 Oct 2026

Prescriptive AI tools shift critical care toward personalized treatment.

Critical care requires rapid decisions from complex, evolving data. Predictive models forecast deterioration but do not guide therapy.

30 Oct 2026

Incisionless brain procedure eliminates Parkinson's tremors for air force veteran

To the untrained eye, a "ham" radio may look like a simple device. However, inside its casing, dozens of delicate wires and tiny elements perform distinct yet connected functions to deliver messages to a vast network of operators around the world.

30 Oct 2026

Targeting specific enzyme reverses radiation-induced immune suppression in cancer

Researchers at the University of Chicago identified a mechanism to make immune cells reprogrammed by radiation therapy attack tumors rather than protect them.

30 Oct 2026

Testosterone shows no evidence of improving menopausal brain fog

Published in Reproduction and Fertility, the review examined five existing studies of women aged 41 to 65 to understand whether testosterone treatment improves thinking and memory in women during and after menopause.

30 Oct 2026

Gut microbial catalog reveals systemic inflammation drivers in spinal injury

Scientists exploring the links between a spinal cord injury, inflammation and immune function have turned their attention to a genome-level analysis of the gut microbial community, with early study results offering hints at potential new approaches to aid healing.

30 Oct 2026

Platelet hyperactivity drives glioblastoma progression and deep vein thrombosis

New Cleveland Clinic research published in Cancer Cell shows that people with glioblastoma have more active platelets, which are cells involved in blood clotting. Platelets also communicate with other cells and can influence immune activity. The overactive platelets in people with glioblastoma slow the activity of cancer-fighting T cells, which can contribute to tumor growth and cancer progression.

30 Oct 2026